ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Telephone-Based Support for Caregivers of Patients With Dementia

This study has been completed.

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00052104
  Purpose

The purpose of this study is to develop an effective, low-cost, telephone-based intervention to reduce anxiety, depression, and feelings of burden and stress in caregivers of patients with dementia. This study will also determine whether the intervention can alter the course of dementia.


Condition Intervention Phase
Dementia
Behavioral: Cognitive-Behavioral Family Systems Intervention
Phase II
Phase III

MedlinePlus related topics:   Caregivers    Dementia   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title:   A Telephone Intervention for Dementia Caregivers

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:   85
Study Start Date:   December 2001
Study Completion Date:   November 2005
Primary Completion Date:   November 2005 (Final data collection date for primary outcome measure)

Detailed Description:

Caregivers are randomized to receive either telephone-based intervention or standard medical care. Both groups receive a resource packet containing information about caring for someone with dementia and a list of local resources. Caregivers in the intervention group also receive a series of telephone calls over 12 months, during which education, emotional support, and training in problem-solving skills are provided by trained therapists. Caregivers in the standard care group receive no additional psychosocial intervention. Participants are assessed pre-treatment, mid-treatment (6 months), post-treatment, and at a 3-month follow-up.

  Eligibility
Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Patient Inclusion Criteria:

  • DSM-IV diagnosis of dementia (vascular, mixed, or associated with Alzheimer's disease)
  • Lives in the community, including senior/retirement centers, but excluding nursing homes and assisted living centers
  • 50 years old or older
  • Resides in Southeastern New England

Caregiver Inclusion Criteria:

  • Living with a person with dementia
  • Provides care for at least 6 months for at least 4 hours a day
  • English as primary language
  • Telephone access
  • Resides in Southeastern New England

Patient Exclusion Criteria:

  • Major acute medical condition affecting independent functioning

Caregiver Exclusion Criteria:

  • Acute medical illness
  • Cognitive impairment as defined by an MMSE score < 25
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00052104

Locations
United States, Rhode Island
Rhode Island Hospital    
      Providence, Rhode Island, United States, 02903

Sponsors and Collaborators
  More Information


Study ID Numbers:   R21 MH62561, DSIR GT-GS
First Received:   January 22, 2003
Last Updated:   March 4, 2008
ClinicalTrials.gov Identifier:   NCT00052104
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Central Nervous System Diseases
Brain Diseases
Dementia
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on November 20, 2008




Links to all studies - primarily for crawlers